Stromedix, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Subsidiary
- Established
- 2006-01-01
- Employees
- 11
- Market Cap
- -
- Website
- http://www.stromedix.com
Study of STX-100 in Renal Transplant Patients With Interstitial Fibrosis and Tubular Atrophy (IF/TA)
Phase 2
Withdrawn
- Conditions
- Chronic Allograft Dysfunction
- Interventions
- Biological: STX-100
- First Posted Date
- 2009-04-09
- Last Posted Date
- 2011-05-23
- Lead Sponsor
- Stromedix, Inc.
- Target Recruit Count
- 48
- Registration Number
- NCT00878761
- Locations
- 🇺🇸
Stromedix Investigative Site, Cambridge, Massachusetts, United States
© Copyright 2025. All Rights Reserved by MedPath